At a glance
ClinicalIndex Comparison RecordN/ACompleted· 97 enrolled
Drug / intervention
Spectra WaveWriter SCS Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
VERITAS - A Study to Demonstrate the Value of Multiple Modalities Using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain
In Brief
A clinical study evaluating Spectra WaveWriter SCS System for Chronic Pain and Back Pain. Completed, enrolled 97 participants across 15 sites.
Detailed Summary
To demonstrate the value of multiple modalities and sustained clinically significant pain relief in patients with chronic pain when using the Boston Scientific Spectra WaveWriter Spinal Cord Stimulator (SCS) System.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain, Back Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartJan 2018
Primary CompletionJan 2019
Study CompletionMar 2020
TodayJul 2026
First PostedAug 16, 2017
Enrollment StartJan 9, 2018
Primary CompletionJan 9, 2019
Study CompletionMar 10, 2020
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 8.9 years ago
Interventions
Spectra WaveWriter SCS Systemdevice
Multiple modalities of stimulation therapy